|
STAT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.65590000000316E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.17529999999777E-05 |
| Normal-vs-Stage2 |
5.816600E-03 |
| Normal-vs-Stage3 |
5.963400E-03 |
| Normal-vs-Stage4 |
5.448100E-02 |
| Stage1-vs-Stage2 |
6.714600E-01 |
| Stage1-vs-Stage3 |
3.932600E-01 |
| Stage1-vs-Stage4 |
6.268600E-01 |
| Stage2-vs-Stage3 |
7.721600E-01 |
| Stage2-vs-Stage4 |
8.784400E-01 |
| Stage3-vs-Stage4 |
9.600000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.04680000000157E-05 |
| Normal-vs-AfricanAmerican |
1.398550E-03 |
| Normal-vs-Asian |
6.591700E-02 |
| Caucasian-vs-AfricanAmerican |
4.328200E-01 |
| Caucasian-vs-Asian |
9.182000E-01 |
| AfricanAmerican-vs-Asian |
8.613800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99119999955944E-07 |
| Normal-vs-Female |
4.857500E-02 |
| Male-vs-Female |
1.139570E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.179830E-04 |
| Normal-vs-Extreme_Weight |
1.67953999999915E-05 |
| Normal-vs-Obese |
3.635900E-03 |
| Normal-vs-Extreme_Obese |
4.279300E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.921800E-01 |
| Normal_Weight-vs-Obese |
1.216610E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.017400E-01 |
| Extreme_Weight-vs-Obese |
8.510300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.290600E-01 |
| Obese-vs-Extreme_Obese |
2.845200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.297800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.336300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.84450000051406E-07 |
| Normal-vs-Age(81-100Yrs) |
6.05129999999843E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.007400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.815060E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.716400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.445300E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.047740E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.705200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.028160E-04 |
| Normal-VS-Type2 PRCC |
3.46019999986069E-07 |
| Normal-VS-KIRP CIMP |
1.001170E-01 |
| Normal-VS-Unclassified PRCC |
3.378400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.017800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.37330000000458E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.276400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.69470000044703E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.260040E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.620800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.65680000005797E-07 |
| Normal-vs-N1 |
1.070800E-01 |
| Normal-vs-N2 |
9.010400E-01 |
| N0-vs-N1 |
5.475800E-02 |
| N0-vs-N2 |
1.811930E-02 |
| N1-vs-N2 |
4.400600E-01 |
|
|
